CIK 0001010086
- Accelerated filer
SIGA TECHNOLOGIES INC
Sign in to watch- Ticker
- SIGA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133864870
- Phone
- +1 212-672-9100
- Business address
- 31 EAST 62ND STREET, NEW YORK, NY, 10065
- Former names
- SIGA PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-09 | Marshall Joseph W III Director | Option exercise | +25,000 | $4.74 | $119K | 143,000 |
| 2019-01-09 | Marshall Joseph W III Director | Shares withheld for taxes | −15,231 | $7.78 | $118K | 127,769 |
| 2019-01-09 | Marshall Joseph W III Director | Option exercise · Stock Option (Right to buy) | −25,000 | 0 | ||
| 2018-12-12 | Luckshire Daniel J Executive VP & CFO | Option exercise | +58,965 | $3.53 | $208K | 234,679 |
| 2018-12-12 | Luckshire Daniel J Executive VP & CFO | Shares withheld for taxes | −28,614 | $6.38 | $183K | 206,065 |
| 2018-12-12 | Luckshire Daniel J Executive VP & CFO | Option exercise · Stock-Settled Stock Appreciation Rights | −132,000 | 0 | ||
| 2018-11-22 | ROSE ERIC A MD Director | Option exercise | +200,000 | 1,098,990 | ||
| 2018-11-22 | ROSE ERIC A MD Director | Shares withheld for taxes | −105,896 | $5.55 | $588K | 993,094 |
| 2018-11-22 | ROSE ERIC A MD Director | Option exercise · Restricted Stock Units | −200,000 | 100,000 | ||
| 2018-11-22 | Gomez Phillip Louis III Chief Executive Officer | Option exercise | +588,236 | 603,236 | ||
| 2018-11-22 | Gomez Phillip Louis III Chief Executive Officer | Shares withheld for taxes | −287,543 | $5.55 | $1.6M | 315,693 |
| 2018-11-22 | Gomez Phillip Louis III Chief Executive Officer | Option exercise · Restricted Stock Units | −588,236 | 294,117 | ||
| 2018-11-16 | SAVAS PAUL G Director | Purchase | +5,000 | $5.58 | $28K | 237,847 |
| 2018-11-13 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −31,099 | $5.29 | $165K | 197,465 |
| 2018-11-12 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −18,901 | $4.96 | $94K | 228,564 |
| 2018-11-12 | Gomez Phillip Louis III Chief Executive Officer | Purchase | +15,000 | $5.20 | $78K | 15,000 |
| 2018-11-12 | SAVAS PAUL G Director | Purchase | +10,000 | $5.01 | $50K | 232,847 |
| 2018-10-16 | BAYER MICHAEL J Director | Option exercise | +25,000 | $3.14 | $79K | 134,500 |
| 2018-10-16 | BAYER MICHAEL J Director | Shares withheld for taxes | −14,756 | $5.32 | $79K | 119,744 |
| 2018-10-16 | BAYER MICHAEL J Director | Option exercise · Stock Option (Right to buy) | −25,000 | 0 |
Page 17 of 28 · 558 trades